SCHEMBL2032829

SCHEMBL2032829

CC(C)(C)[C@@H](N)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL738238 1.00
SCHEMBL1534982 1.00
Hydrochloric Acid SCHEMBL27147331 0.97 DPP4 (0.43)
Hydrochloric Acid SCHEMBL1217456 0.97 DPP4 (0.43)
Hydrochloric Acid SCHEMBL14152640 0.97 DPP4 (0.43)
Trifluoroacetic Acid SCHEMBL4683202 0.85 ALDH1A1 (0.38)
Trifluoroacetic Acid SCHEMBL30154872 0.85 ALDH1A1 (0.38)
SCHEMBL29617079 0.84
SCHEMBL21955854 0.79
SCHEMBL7335094 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332485-B2 Penicillin-binding protein inhibitors VenatoRx Pharmaceuticals, Inc. (US) 2022-05-17 US disclosed
US-20200157123-A1 PENICILLIN-BINDING PROTEIN INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-05-21 US disclosed
EP-3630782-A1 PENICILLIN-BINDING PROTEIN INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2020-04-08 EP disclosed
CN-110959008-A Penicillin binding protein inhibitors 维纳拓尔斯制药公司 2020-04-03 CN disclosed
WO-2018218190-A1 PENICILLIN-BINDING PROTEIN INHIBITORS VenatoRx Pharmaceuticals, Inc. (US) 2018-11-29 WO disclosed
JP-2011126825-A METHOD FOR PURIFYING OPTICALLY ACTIVE tert-LEUCINAMIDE MITSUBISHI GAS CHEMICAL CO INC 2011-06-30 JP disclosed
JP-2002253293-A METHOD FOR PRODUCING OPTICALLY ACTIVE L-tert-LEUCINE MITSUBISHI GAS CHEM CO INC 2002-09-10 JP disclosed